Tuesday, November 3, 2026

Rokit Healthcare’s AI Skin Regeneration: A Comprehensive Guide to Upcoming Innovations in China

Rokit Healthcare showcases AI-based skin regeneration technology at a local medical device fair in China, invited by the government.

Kim Jong Un Celebrates 80th Anniversary of Youth Alliance: What It Means for North Korea’s Future?

Kim Jong Un celebrated the 80th anniversary of the Socialist Patriotic Youth League, emphasizing youth's vital role in North Korea's future.

NATION OF ANXIETY: President Lee is Making Agenda without Knowing Basic Facts: Citizens Were Held In North

Kim Geon criticizes President Lee for ignorance on South Koreans detained in North Korea, urging prioritization of their safety.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

Celltrion Launches Omlyclo in Brazil: How This First Mover is Revolutionizing Autoimmune Treatment

Celltrion launched Omlyclo in Brazil, aiming to boost market penetration and strengthen ties with local medical professionals.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Classys Unveils Aggressive Growth Strategy at AAD 2026: What’s Next for the U.S. Market?

Classys reveals its growth strategy for the U.S. market at AAD 2026, showcasing innovative products and emphasizing clinical efficacy.

Rokit Healthcare’s Groundbreaking Kidney Regeneration Patent: What It Means for Patients and the Market

Rokit Healthcare secures a U.S. patent for kidney regeneration, aiming to revolutionize treatment and collaboration with Harvard Medical School.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

Can Kidney Transplant Improve Blood Disorders? New Study Reveals Surprising Results for Patients with Aplastic Anemia

A study shows kidney transplants can improve outcomes in patients with severe aplastic anemia and end-stage renal failure.

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Yuhan Corporation Partners with Huinno: A Game Changer for AI-Based ECG Monitoring in the U.S. Market

Yuhan Corporation partners with Huey No for a strategic agreement to enter the U.S. digital healthcare market.

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

Unlock Radiant Skin: LABSENN’s Calming Serum Offers Powerful Anti-Aging Benefits

HLB Peptide launches LABSENN, a derma-science brand featuring innovative peptide technology and the Peptide Calming Serum for sensitive skin.

2026 Senior Care Market: CareLabs’ Bold New Venture Explained

CareLabs CEO Lee Min-kyung announces plans to enter the senior care market, leveraging digital healthcare for growth and innovation.

Discover the Future of Skincare: Humedix Unveils Re2O ECM at Cosmoprof Bologna 2026

Humedix showcased its Elravie Cosmetic line at Cosmoprof Bologna 2026, featuring the innovative Re2O ECM skin booster for global expansion.

Wantech Targets U.S. Market Expansion at AAD 2026: Key Strategies Revealed

Wontech aims to expand in the U.S. by showcasing products at the AAD and hosting Wave Denver 2026 for healthcare partnerships.

How Will Korea’s New R&D-Linked Drug Pricing Impact the Pharma Industry in 2026?

The new drug pricing reform aims to boost R&D in the pharmaceutical industry, but raises concerns for smaller firms facing cash flow issues.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.